Correlation Between SCANDMEDICAL SOLDK and AlzChem Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK and AlzChem Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK and AlzChem Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and AlzChem Group AG, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK and AlzChem Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK with a short position of AlzChem Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK and AlzChem Group.

Diversification Opportunities for SCANDMEDICAL SOLDK and AlzChem Group

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between SCANDMEDICAL and AlzChem is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and AlzChem Group AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzChem Group AG and SCANDMEDICAL SOLDK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with AlzChem Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzChem Group AG has no effect on the direction of SCANDMEDICAL SOLDK i.e., SCANDMEDICAL SOLDK and AlzChem Group go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK and AlzChem Group

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to under-perform the AlzChem Group. But the stock apears to be less risky and, when comparing its historical volatility, SCANDMEDICAL SOLDK 040 is 1.19 times less risky than AlzChem Group. The stock trades about -0.07 of its potential returns per unit of risk. The AlzChem Group AG is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  5,660  in AlzChem Group AG on October 26, 2024 and sell it today you would earn a total of  800.00  from holding AlzChem Group AG or generate 14.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy94.74%
ValuesDaily Returns

SCANDMEDICAL SOLDK 040  vs.  AlzChem Group AG

 Performance 
       Timeline  
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
AlzChem Group AG 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AlzChem Group AG are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, AlzChem Group exhibited solid returns over the last few months and may actually be approaching a breakup point.

SCANDMEDICAL SOLDK and AlzChem Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SCANDMEDICAL SOLDK and AlzChem Group

The main advantage of trading using opposite SCANDMEDICAL SOLDK and AlzChem Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK position performs unexpectedly, AlzChem Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzChem Group will offset losses from the drop in AlzChem Group's long position.
The idea behind SCANDMEDICAL SOLDK 040 and AlzChem Group AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance